2027年3月期第1四半期決算説明会動画配信及び資料掲載のお知らせ

短信 2027年3月期第1四半期決算短信〔日本基準〕（連結）

説明会資料 2027年3月期 第１四半期決算説明会資料

説明会資料 2027年3月期 第１四半期決算説明会 動画配信

取締役及び従業員に対する譲渡制限付株式としての自己株式処分の払込完了に関するお知らせ

取締役及び従業員に対する譲渡制限付株式としての自己株式処分に関するお知らせ

事業報告書・株主通信 第28期 事業報告書（株主のみなさまへ）

株主総会 第28期定時株主総会 動画配信

株主総会 第28期定時株主総会終了ご通知

有価証券報告書 有価証券報告書（第28期）

ess release Correction to some of the information contained in the notice of convocation of the 28th Ordinary General Meeting of Shareholders

General meeting of shareholders Notice of Convocation of the 28th Ordinary General Meeting of Shareholders

General meeting of shareholders Materials for the 28th Ordinary General Meeting of Shareholders (Items omitted from the distributed documents)

ess release Notice Regarding the Absorption Merger of a Subsidiary of Our Consolidated Subsidiaries and Absorption Mergers Between Consolidated Subsidiaries

ess release Notice Regarding the Absorption Merger of a Subsidiary of Our Consolidated Subsidiaries and Absorption Mergers Between Consolidated Subsidiaries

ess release (Changes to Disclosure Items) Notice Regarding the Reorganization of Business Functions Following the Closure of the Kobe Research Institute

calendar Financial Results Briefing for the Fiscal Year Ending March 2026 - For institutional investors, analysts, and the media (held online)

ess release Notice Regarding Recognition of Extraordinary Losses and Deferred Tax Assets, Differences Between Full-Year Consolidated Earnings Forecast and Actual Results, and Differences Between Individual Earnings and Previous Year's Results

ess release Notice regarding debt waiver for consolidated subsidiary

Materials for financial results bliefings Financial Results Presentation Materials for the Fiscal Year Ending March 2026

ess release Announcement Regarding Video Distribution and Publication of Materials for the FY2026 Financial Results Briefing

説明会資料 2026年3月期 決算説明会資料

Materials for financial results bliefings Video streaming of the FY2026 earnings briefing.

Earnings summary earnings summary for the fiscal year ending March 2026 [Japanese standards] (consolidated)

ess release Notice of US Patent Grant Regarding "Exon Humanized Mice"

ess release Notice Regarding the Closure of Transgenic Kobe Research Institute Co., Ltd. (hereinafter referred to as "Kobe Research Institute")

rmation on media publicity "Wellness Monthly Report No. 93" features an interview article with our group company, Transgenic Co., Ltd.

rmation on media publicity "Wellness Monthly Report No. 93" features an interview article with our group company, Transgenic Co., Ltd.

ess release Notice regarding change of listing market classification to the Tokyo Stock Exchange Standard Market

ess release Notice regarding approval of market classification change to the Tokyo Stock Exchange Standard Market and withdrawal of the "Plan to comply with the listing maintenance standards"

Materials for financial results bliefings Third Quarter Financial Results Briefing for the Fiscal Year Ending March 2026

Earnings summary earnings summary for the third quarter of the fiscal year ending March 31, 2026 [Japanese GAAP] (consolidated)

Materials for financial results bliefings Third Quarter Financial Results Briefing for the Fiscal Year Ending March 2026 Video Streaming

ess release Announcement of video streaming and publication of materials for the third quarter financial results briefing for the fiscal year ending March 2026

Research and development column History of Liver-Humanized Mice Episode 20, Extra Part 2

Note New Year Greetings

Note New Year Greetings

研究開発コラム 肝臓ヒト化マウスの歴史　第２０話

ess release Update (change) of the plan to comply with the listing maintenance standards

ess release Results of GLP Compliance Inspection at TransGenic Co., Ltd., a Subsidiary of Our Company

calendar Third Quarter Financial Results Briefing for the Fiscal Year Ending March 2026 - For institutional investors, analysts, and the media (online)

Business Report / Integrated Report 28th Interim Report

研究開発コラム 肝臓ヒト化マウスの歴史　第１９話

Securities report Semi-Annual Report (28th Term, 2nd Quarter)

ess release Announcement of video streaming and publication of materials for the second quarter financial results briefing for the fiscal year ending March 2026

Earnings summary earnings summary for the second quarter (interim period) of the fiscal year ending March 2026 [Japanese GAAP] (consolidated)

Materials for financial results bliefings Interim financial results briefing materials for the fiscal year ending March 2026

Materials for financial results bliefings Video streaming of the interim financial results briefing for the fiscal year ending March 2026

Materials for financial results bliefings Interim financial results briefing materials for the fiscal year ending March 2026

calendar Interim Financial Results Briefing for the Fiscal Year Ending March 2026 - For institutional investors, analysts, and the media (held online)

研究開発コラム 肝臓ヒト化マウスの歴史　第１８話 番外編

ess release Notice regarding business collaboration agreement between our company and its consolidated subsidiary, Transgenic Inc., and Hokkaido System Science Co., Ltd.

ess release Notice regarding business collaboration agreement between our company and its consolidated subsidiary, Transgenic Inc., and Hokkaido System Science Co., Ltd.

研究開発コラム 肝臓ヒト化マウスの歴史　第１８話

ess release Notice regarding the expansion of the business partnership between our company (including group companies) and A-Cell Co., Ltd. - Building a new evaluation system through collaboration between "non-clinical trials and human cell evaluation" -

ess release Notice regarding the expansion of the business partnership between our company (including group companies) and A-Cell Co., Ltd. - Building a new evaluation system through collaboration between "non-clinical trials and human cell evaluation" -